Analyst Upgrades

• Micron (MU) to buy from neutral at UBS.
• Baker Hughes (BHI) to outperform from market perform at BMO Capital.
• PDL BioPharma (PDLI) to outperform from sector perform at RBC Capital.
• Fluor (FLR) and Rush Enterprises (RUSHA) to buy from neutral at BofA/Merrill.
• Camden Property (CPT) to outperform from neutral at Macquarie.
• Pinnacle Financial (PNFP) to buy from hold at Wunderlich.
• Linear Technology (LLTC) to neutral from reduce at Nomura.
• Hologic (HOLX) and Illumina (ILMN) to buy from hold at Citigroup.
• F5 Networks (FFIV) to buy from neutral at Gleacher.

Analyst Upgrades

• Amgen (AMGN) to overweight from neutral at Piper Jaffray.
• Goodrich Petroleum (GDP) to outperform from market perform at Wells Fargo.
• Tutor Perini (TPC) to buy from neutral at UBS.
• Covidien (COV) to buy from neutral at Goldman.
• Sara Lee (SLE) and Comcast (CMCSA) to outperform from market perform at Bernstein.
• Research In Motion (RIMM) to outperform from sector perform at FBN Securities.

Analyst Upgrades

• HSBC upgraded Massey Energy (MEE) to overweight from neutral based on improved 2011 pricing power given industry supply-side discipline. Despite the upgrade, the firm cuts its price target to $40 from $54.
• Needham upgraded Blue Coat Systems (BCSI) to buy from hold following yesterday's announcement that Michael J. Borman has been named the new CEO. The firm has a $27 price target on the stock.
• Citigroup upgraded Teekay Offshore Partners (TOO) to buy from hold after the company announced shuttle tanker contracts to reflect improved operating performance. The firm raised its target for shares to $26 from $15.
• Prosperity Bancshares (PRSP) was upgraded to equal weight from underweight at Morgan Stanley.
• Ceradyne (CRDN) was upgraded to buy from hold at Benchmark Co.
• CTC Media (CTCM) was upgraded to buy from hold at Deutsche Bank.

Analyst Upgrades

• Wunderlich upgraded Inergy (NRGY) to buy from hold on valuation after the stock sold off following the proposed merger with Inergy Holdings (NRGP). The firm raised its target for shares to $46 from $40.
• Soleil upgraded Applied Industrial (AIT) to buy from gradually accumulate following the company's better-than-expected Q4 results and raised its target for shares to $42 from $36.
• Citigroup upgraded Starwood Property (STWD) to buy from hold with a $21 price target, citing a pick-up in CRE loan sales.
• Family Dollar (FDO) was upgraded to overweight from equal weight at Barclays.
• Intercontinental Hotels (IHG) was upgraded to buy from sell at Societe Generale.
• Yucheng Technologies (YTEC) was upgraded to buy from hold at Roth Capital.

Analyst Upgrades

• Thomas Weisel upgraded Deckers Outdoor (DECK) to overweight from market weight following channel checks. The firm also raised its target for shares to $170 from $162.
• Deutsche Bank upgraded Amerigroup (AGP) to buy from hold as it believes the company is well positioned to benefit from health care reform. The firm upped its target for shares to $42 from $38.
• Cowen upgraded Cubist Pharmaceuticals (CBST) to outperform from neutral, citing increased conviction in Cubicin's patent exclusivity.
• OmniVision (OVTI) was upgraded to strong buy from buy at Needham.
• Take-Two (TTWO) was upgraded to buy from hold at ThinkEquity.
• Wells Fargo (WFC) was upgraded to buy from neutral at Sterne Agee.

Analyst Upgrades

• RBC Capital upgraded Suncor (SU) to outperform from sector perform following the Q1 report and FY10 production guidance. The firm has a $46 target on the stock.
• Wells Fargo upgraded Clear Channel Outdoor (CCO) to outperform from market perform. The firm expects the company to report higher-than-expected Q1 revenue and guidance, as it thinks a late cycle ad recovery is occurring.
• Piper Jaffray upgraded Power Integrations (POWI) to overweight from neutral following the company's Q1 results and subsequent sell-off. The firm has a $43 price target for shares.
• ArcelorMittal (MT) was upgraded to buy from hold at ING Group.
• Sapient (SAPE) was raised to conviction buy from buy at Goldman and to buy from hold at Citigroup.
• Powerwave (PWAV) was upgraded to buy from hold at Befferies and to buy from neutral at Merriman.

"We use a combination of fundamental, technical and sentiment indicators -- combined with a contrarian investment approach -- to select both our long and short trading ideas," says Bernie Schaeffer.

The editor of The Options Advisor explains, "In the tech sector, we recommend calls on software company Blue Coat Systems (BCSI) while also recommend buying puts on Internet security firm McAffee (MFE).

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

"My pick for 2010 is Blue Coat Systems (BCSI), a company that provides web security," says Leo Fasciocco, a leading technical analyst known for his focus on stocks that are breaking out of basing patterns.

In his The Ticker Tape Digest, he explains, "We consider the stock an excellent intermediate-term play because of its strong profit outlook."

Analyst Upgrades

• Goldman upgraded Potash (POT) to conviction buy from buy and said a "near-worst-case" scenario on 2010 potash pricing is reflected in potash valuations and that they continue to expect a fundamental potash demand recovery in 2010. Note that the firm also upgraded Mosaic (MOS) to buy from neutral. Potash's price target is $138.
• Morgan Stanley upgraded Alcoa (AA) to overweight from equal weight based on expectations for alumina to continue to rally in 2H10. The firm has a $22 target on the stock.
• Baird upgraded Seagate (STX) to outperform from neutral and raised its target to $25 from $22 based on expectations that IT hardware spend will continue to accelerate through 2010, HDD supply conditions will continue to be constrained at least into the March quarter, and that enterprise strength and favorable supply conditions will drive shares higher in 2010.
• Intel (INTC) was upgraded to overweight from equal weight at Barclays.
• Resource Capital (RSO) was raised to outperform from market perform at FBR Capital.
• Palm (PALM) was upgraded to hold from sell at Morgan Joseph.

Analyst upgrades:

• Keefe Bruyette upgraded Bank of America (NYSE:BAC) to Outperform from Market Perform due to valuation and the company's better balance sheet following capital raises. The firm raised its target on shares to $16.50.
  
• Merriman upgraded Blue Coat Systems (NASDAQ:BCSI) to Buy from Neutral to reflect stabilizing demand and merger synergies from the Packeteer acquisition.
  
• Thomas Weisel upgraded Genomic Health (NASDAQ:GHDX) to Overweight from Market Weight based on valuation, a new colon cancer assay expected in 2010, and upside from new sales hires.
• Plexus (NASDAQ:PLXS) was upgraded to Outperform from Neutral at Baird.
  
• Great Plains Energy (NYSE:GXP) was raised to Buy from Neutral at Goldman.
  
• Ericsson (nASDAQ:ERIC) was upgraded at Societe Generale to Buy from Hold.

Analyst upgrades:

• JMP Securities upgraded Salesforce.com (NYSE: CRM) to Outperform from Market Perform based on valuation.
  
• Goldman Sachs upgraded Chico's (NYSE: CHS) to Neutral from Sell based on valuation.
• Blue Coat (NASDAQ: BCSI) was raised to Hold from Sell by Brean Murray.

Analyst downgrades:

• UBS dropped Burger King (NYSE: BKC) to Neutral from Buy due to the company's slowing sales trends and commodity pressure.
  
• Las Vegas Sands (NYSE: LVS) was downgraded to Sell from Neutral by Banc of America based on valuation.
  
• Pacific Sunwear (NASDAQ: PSUN) was downgraded to Neutral from Outperform by Baird, which cited the company's Q2 results and reduced guidance.

Analyst initiations:

• UBS initiated O'Reilly (NASDAQ: ORLY) with a Buy because they are positive on its recent CSK Auto acquisition and its valuation.
  
• Baird started Amedisys (NASDAQ: AMED) with an Outperform because they view the recent pullback in the shares as a compelling entry point.

MOST NOTEWORTHY: Teva Pharmaceutical, Blue Coat Systems and American International Group were today's noteworthy upgrades:

• Deutsche Bank upgraded shares of Teva Pharmaceutical (NASDAQ: TEVA) to Buy from Hold to reflect the company's greater growth prospects following the acquisition of Barr (NYSE: BRL). The firm raised the target to $56 from $47.
  
• ThinkPanmure upgraded Blue Coat Systems (NASDAQ: BCSI) to Buy from Source of Funds based on the company's growth prospects following positive channel checks.
  
• American International Group (NYSE: AIG) was raised to Buy from Neutral at Banc of America on valuation, as they find the risk/reward attractive at current levels.

OTHER UPGRADES:

• Goldman upgraded the Semiconductor Production Equipment sector to Neutral from Cautious and added Verigy (NASDAQ: VRGY) to its Conviction Buy List.
  
• Morgan Stanley upgraded Whole Foods (NASDAQ: WFMI) and Cintas (NASDAQ: CTAS) to Equal Weight from Underweight.
  
• Gibraltar Industries (NASDAQ: ROCK) was raised to Buy from Neutral at Piper.

MOST NOTEWORTHY: Monogram Biosciences, Interpublic Group and Blue Coat Systems were today's noteworthy initiations:

• JMP Securities said Monogram Biosciences (NASDAQ: MGRM) has a broad platform enabling it to develop multiple personalized medicine product offerings and has significant growth prospects from its HIV diagnostic business and its diagnostic test in oncology. Shares were initiated with an Outperform rating and $3.50 target.
  
• Jefferies assumed Interpublic Group (NYSE: IPG) with a Buy rating and $11 target. The firm believes the current valuation does not reflect the company's turnaround, which they believe is gaining traction.
  
• Friedman Billings initiated Blue Coat Systems (NASDAQ: BCSI) with a Market Perform rating and $18 target. The firm prefers to wait on the sidelines given the near-term headwinds from a difficult spending environment in North America and integration risks from the Packeteer acquisition.

OTHER INITIATIONS:

• American Capital (NASDAQ: AGNC) was initiated at Merrill with a Buy rating and at RBC Capital with an Outperform rating and $32 target.
  
• UBS assumed Quality Systems (NASDAQ: QSII) with a Buy rating and $39 target.
• HSBC initiated Daimler AG (NYSE: DAI) with an Overweight rating.

MOST NOTEWORTHY: AbitibiBowater, GlaxoSmithKline, AstraZeneca and Capital One were today's noteworthy downgrades:

• Lehman downgraded AbitibiBowater (NYSE: ABH) to Equal Weight from Overweight citing dilution from the recent $350M convertible offering, cost pressures, and a more cautious outlook near-term for pulp markets.
  
• JP Morgan cut GlaxoSmithKline (NYSE: GSK) and AstraZeneca (NYSE: AZN) to Underweight from Neutral on long-term earnings growth concerns.
  
• Keefe Bruyette lowered Capital One (NYSE: COF) to Underperform from Market Perform to reflect the company's credit outlook.

OTHER DOWNGRADES:

• Nokia (NYSE: NOK) was downgraded to Neutral from Buy at UBS and to Underweight from Overweight at JP Morgan.
  
• Textron (NYSE: TXT) was cut at Credit Suisse to Neutral from Outperform.
  
• Merriman downgraded Blue Coat Systems (NASDAQ: BCSI) to Neutral from Buy.

MOST NOTEWORTHY: Greatbatch and Blue Coat Systems were today's noteworthy initiations:

• Piper assumed coverage of Greatbatch (NYSE: GB) with a Neutral rating and $19.50 target as they believe acquisition-related expenses will weigh on near-term bottom-line results.
  
• Collins Stewart believes shares of Blue Coat Systems (NASDAQ: BCSI) are highly attractive at current levels. The firm started shares with a Buy rating and $29 target.

OTHER INITIATIONS:

• Ultra Petroleum (NYSE: UPL) was initiated at Credit Suisse with an Outperform rating and $82 target.
  
• Lehman assumed Dana Holding (NYSE: DAN) with an Overweight rating and $15 target.